Based on the literature data available, the only PSMA-targeting radiopharmaceutical used for detecting HCC lesions was [68Ga]Ga-PSMA-11 [28,29,30,31,32,33]. The gene discussed is FOLH1; the disease is hepatocellular carcinoma.